Status:
COMPLETED
Neurological Impacts of Artificial Sweeteners in the Context of Diet Sodas
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study seeks to determine whether artificial sweeteners in the context of diet soda may alter the brain's response to food cues and thus impact appetite.
Eligibility Criteria
Inclusion
- Men and women who are 18-65 years old, with a BMI \>30kg/m2.
Exclusion
- Unable or unwilling to participate in the study for any reason
- Metal in the body or other safety concerns which makes patient unable to have an MRI
- Pregnant women will be excluded to protect the fetus against potential effects of a non-medically required MRI on fetal development and difficulty of measuring accurate BMI.
Key Trial Info
Start Date :
August 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04048681
Start Date
August 6 2019
End Date
December 20 2019
Last Update
February 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center MRI Research Facility
Boston, Massachusetts, United States, 02215